Montgomery M O, Litvin J, Gonzalez-Sanchez A, Bader D
Cornell University Medical College, Department of Cell Biology and Anatomy, New York, NY 10021.
Dev Biol. 1994 Jul;164(1):63-71. doi: 10.1006/dbio.1994.1180.
The present study establishes the earliest time point for commitment of cardiac myocyte progenitors at gastrulation and determines the effects of bromodeoxyuridine (BrdU) on postgastrulated committed cardiac progenitor cells at a molecular level. Using immunochemical and reverse transcription/polymerase chain reaction assays for cardiac muscle-specific gene expression, we found that while both pre- and postgastrulated embryonic cells were capable of cardiogenic differentiation at high cell density, only postgastrulated cells exhibited the ability to differentiate at clonal density. These data indicate that while cardiac myocyte differentiation of pregastrulated cells can occur in vitro, cell-cell interactions are necessary for this to happen. Only gastrulated cardiac progenitor cells are able to differentiate in the absence of cell-cell interactions and are therefore both specified and committed. Next, by exposing postgastrulated committed cardiac progenitor cells from embryos at various stages to BrdU, we demonstrated that these cells from the lateral-plate mesoderm vary in their ability to differentiate into cardiac myocytes in vitro. Differentiation of cardiac myocyte progenitor cells from stages 4 and 5 was completely blocked by BrdU, whereas it was not blocked in cells from stages 7 and 8 and cells from stage 6 were varied in their reaction. Analysis of cardiac myogenesis in vivo revealed that cardiac progenitors acquire BrdU resistance as they migrate, postgastrulation, anteriorly along a rostrocaudal axis. The results from these two experiments suggest that while pregastrulated cells exhibit a limited ability to undergo cardiac myocyte differentiation, only postgastrulated anterior lateral-plate mesoderm contains committed cardiac myocyte progenitors and that these committed progenitors are not equivalent in their ability to differentiate.
本研究确定了原肠胚形成期心脏肌细胞祖细胞定向分化的最早时间点,并在分子水平上确定了溴脱氧尿苷(BrdU)对原肠胚形成后定向分化的心脏祖细胞的影响。通过免疫化学和逆转录/聚合酶链反应分析心肌特异性基因表达,我们发现,虽然原肠胚形成前和形成后的胚胎细胞在高细胞密度下都能够进行心脏分化,但只有原肠胚形成后的细胞在克隆密度下表现出分化能力。这些数据表明,虽然原肠胚形成前的细胞在体外可以发生心肌分化,但这种情况发生需要细胞间相互作用。只有原肠胚形成后的心脏祖细胞能够在没有细胞间相互作用的情况下分化,因此它们既已确定又已定向。接下来,通过将不同阶段胚胎的原肠胚形成后定向分化的心脏祖细胞暴露于BrdU,我们证明来自侧板中胚层的这些细胞在体外分化为心肌细胞的能力各不相同。来自第4和第5阶段的心肌细胞祖细胞的分化被BrdU完全阻断,而来自第7和第8阶段的细胞未被阻断,来自第6阶段的细胞反应各异。对体内心脏发生的分析表明,心脏祖细胞在原肠胚形成后沿头尾轴向前迁移时获得了对BrdU的抗性。这两个实验的结果表明,虽然原肠胚形成前的细胞进行心肌分化的能力有限,但只有原肠胚形成后的前侧板中胚层含有定向分化的心肌细胞祖细胞,并且这些定向祖细胞的分化能力并不相同。